External quality assessment schemes for glucose measurements in Germany: factors for successful participation, analytical performance and medical impact.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Geilenkeuser, Wolf J
Thaler, Markus A
Luppa, Peter B
MetadataShow full item record
AbstractDetermination of blood glucose concentration is one of the most important measurements in clinical chemistry worldwide. Analyzers in central laboratories (CL) and point-of-care tests (POCT) are both frequently used. In Germany, regular participation in external quality assessment (EQA) schemes is mandatory for laboratories performing glucose testing. Glucose testing data from the two German EQAs "Reference Institute for Bioanalytics" (RfB) and "INSTAND - Gesellschaft zur Förderung der Qualitätssicherung in medizinischen Laboratorien" (Instand) were analyzed from 2012 to 2016. Multivariable odds ratios (OR) for the probability to reach a "good" result were calculated. Imprecision and bias were determined and clinical risk of measurement errors estimated. The device employed was the most important variable required for a "good" performance in all EQAs. Additional participation in an EQA for CL automated analyzers improved performance in POCT EQAs. The reciprocal effect was less pronounced. New participants performed worse than experienced participants especially in CL EQAs. Imprecision was generally smaller for CL, but some POCT devices reached a comparable performance. Large lot-to-lot differences occurred in over 10% of analyzed cases. We propose the "bias budget" as a new metric to express the maximum allowable bias that still carries acceptable medical risk. Bias budgets were smallest and clinical risks of errors greatest in the low range of measurement 60-115 mg/dL (3.3-6.4 mmol/L) for most devices. EQAs help to maintain high analytical performances. They generate important data that serve as the foundation for learning and improvement in the laboratory healthcare system.
AffiliationHZI,Helmholtz-Zentrum für Infektionsforschung GmbH, Inhoffenstr. 7,38124 Braunschweig, Germany.
The following license files are associated with this item:
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-ShareAlike 3.0 United States
- Effect of Participating in a Quality Improvement System over Time for Point-of-Care C-Reactive Protein, Glucose, and Hemoglobin Testing.
- Authors: Bukve T, Stavelin A, Sandberg S
- Issue date: 2016 Nov
- Expressing analytical performance from multi-sample evaluation in laboratory EQA.
- Authors: Thelen MHM, Jansen RTP, Weykamp CW, Steigstra H, Meijer R, Cobbaert CM
- Issue date: 2017 Aug 28
- Does proficiency testing improve the quality of hantavirus serodiagnostics? Experiences with INSTAND EQA schemes.
- Authors: Hofmann J, Grunert HP, Donoso-Mantke O, Zeichhardt H, Kruger DH
- Issue date: 2015 Oct
- Improving the quality of point-of-care testing.
- Authors: Price CP, Smith I, Van den Bruel A
- Issue date: 2018 Jul 23
- The external quality assessment schemes in Thailand.
- Authors: Opartkiattikul N, Bejrachandra S
- Issue date: 2002 Feb